Kaleo (Formerly Known As Intelliject, Inc.)
111 Virginia Street, Ste 300
Richmond
Virgina
23219
United States
Website: http://www.kaleopharma.com/
24 articles about Kaleo (Formerly Known As Intelliject, Inc.)
-
GSK withdrew three patents related to its asthma inhalers while Impax delisted both of its patents for Adrenaclick and Kaléo delisted eight patents covering Auvi-Q—the companies’ respective epinephrine auto-injectors.
-
U.S. Department of Defense Selects Kaléo to Develop Next Generation Nerve Agent Countermeasure
7/18/2023
Kaléo announced their selection by the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical to develop a reconstitution auto-injector device that delivers atropine, the Reconstitution Auto-Injector Device – Atropine.
-
Tredegar Completes the Sale of Ownership Interest in kaléo
12/28/2021
Tredegar Corporation reported that it has completed the sale of its approximate 18% ownership interest in kaleo, Inc pursuant to an agreement dated November 28, 2021, whereby Marathon Asset Management provided kaléo shareholders a full liquidity event opportunity.
-
Walgreens and Kaléo Expand Retail Pharmacy Collaboration to Include AUVI-q® (epinephrine injection, USP) 0.1 mg, the Only FDA-Approved Epinephrine Auto-Injector for Infants and Toddlers, 16.5 – 33 lbs
7/11/2019
Full AUVI-Q product line available at Walgreens locations nationwide at no cost to commercially insured patients and those who are eligible for kaleo’s patient support programs
-
Scott Gottlieb, commissioner of the Food and Drug Administration (FDA) is notoriously outspoken. Let’s take a look at some of Gottlieb’s more recent statements.
-
U.S. FDA Approves Kaleo's AUVI-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
11/20/2017
AUVI-Q is a compact epinephrine auto-injector with industry-first features, including a voice prompt system that guides a user with step-by-step instructions through the delivery process, and a needle that automatically retracts following administration.
-
Kaleo Donates Thousands Of AUVI-Q (Epinephrine Injection, USP) And EVZIO (Naloxone HCl injection) Auto-Injectors To Hurricane Harvey Relief Efforts
9/5/2017
-
U.S. FDA Grants Priority Review For An Epinephrine Auto-Injector In Development By Kaleo Specifically For Infants And Small Children
7/27/2017
-
Kaleo Donates 250,000th EVZIO (naloxone HCl injection) Auto-Injector To Help Fight Opioid Overdose Epidemic
6/22/2017
-
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio
2/10/2017
-
Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions
1/19/2017
-
Mylan Rival Kaleo Will Re-Launch EpiPen Competitor After Being Yanked From Market Last Year
10/26/2016
-
Kaleo Presents Studies At PAINWeek 2016 Comparing Naloxone Intramuscular Injection And Naloxone Intranasal Administration
9/8/2016
-
Kaleo Release: More Than 1000 Lives Reported Saved With Help Of EVZIO (naloxone HCl injection) Auto-injectors
3/29/2016
-
Sanofi US To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo
2/24/2016
-
Kaleo Announces The Award Of Its 100th Patent
1/26/2016
-
Kaleo To Donate 50,000 EVZIO (naloxone Hcl Injection) Auto-Injectors In Honor Of The UNITE To Face Addiction Rally
9/30/2015
-
Kaleo Release: More than 100 Lives Reported Saved Since Launch Of The "kaleo Cares" EVZIO® (naloxone HCl injection) Donation Program
8/31/2015
-
Kaleo Supports Opioid Overdose Emergency Treatment Efforts With EVZIO™ (Naloxone Hcl Injection) Donations To Local Law Enforcement Agencies
10/29/2014
-
Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose
7/10/2014